Vasculitis related genes cause inflammation of blood vessels

August 2, 2012

(Medical Xpress) -- Medical Scientists at Trinity College Dublin in a pan-European collaborative study have discovered genes that contribute to the condition vasculitis, causing the inflammation of blood vessels. The findings have been recently published in the leading international publication The New England Journal of Medicine.

Vasculitis can affect all sizes of , including tiny vessels only visible with the aid of a . When a blood vessel becomes inflamed, damage to the tissue to which it supplies ensues.  These conditions may be difficult to diagnose and the events that lead to vasculitis are poorly understood. Genetic factors are known to be involved and details of these genes were revealed in the international study to which the School of Medicine’s Department of Immunology was a contributing centre.  

The study focused on one type of vasculitis called ‘granulomatosis with polyangiitis’ (GPA), an auto-immune disease where cells and other components of the immune system are responsible for the inflammation. GPA is potentially a life threatening condition and its diagnosis has been revolutionised by the development of an antibody test, called the C-ANCA antibody.  This test was introduced in Trinity’s Department of Immunology 15 years ago through which it was  established that this condition was much more common than previously known. More than 250 patients with samples analysed in the Department of Immunology laboratory have been diagnosed over this 15 year time period.  

Through the use of the C-ANCA test, GPA can be diagnosed very specifically and this is a critical detail in entering patients for genetic screening studies.  In this recent study, a powerful method of identifying these examining single nucleotide polymorphisms, was applied to a large group of patients with GPA.  In the first part of the study, 1,223 patients from the UK were investigated and the findings were then confirmed and replicated in 1,454 Northern European patients, including a cohort from  Department of Immunology in St James’s Hospital.  The patients with the C-ANCA antibody possessed a distinct immune-related gene profile which differentiated them from GPA patients with a separate type of auto-antibody, referred to as P-ANCA. 

Commenting on these findings, Professor Conleth Feighery, Emeritus Professor of Immunology and Consultant Immunologist at St James’s Hospital says: “These results not only identify key genetic factors contributing to this inflammatory disease but this in turn could lead to more specific therapies targeting components of the immune system.”

The recently appointed Professor of Nephrology in TCD, Professor Mark Little was also a co-author of this study and has been awarded a research grant to focus on disease mechanisms involved in GPA.  

The lead author of the study was Professor Kenneth GC Smith at the Cambridge Institute for Medical Research at Addenbrooke's Hospital. Other prominent centres included the University of Birmingham, the University of Groningen and Maastricht University  and the Karolinska University Hospital in Sweden and many more.

Explore further: ANCA-associated vasculitis has genetic component

Related Stories

ANCA-associated vasculitis has genetic component

July 19, 2012
(HealthDay) -- A genome-wide association study of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis shows a genetic contribution to disease susceptibility, which differs between granulomatosis with polyangiitis ...

Why some kidney disease patients can't repair blood vessels

October 27, 2011
In some kidney diseases, patients have high blood levels of a protein that blocks blood vessel repair, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). Inhibiting ...

Breakthrough in understanding human immune response has potential for the development of new drug therapies

July 6, 2012
(Medical Xpress) -- A team of researchers at Trinity College Dublin’s School of Medicine has gained new insights into a protein in the human immune system that plays a key role in the protective response to infection ...

Long-term rituximab safe for patients with wegener's

July 2, 2012
(HealthDay) -- Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener's), a primary ...

Researchers make breakthrough in the cause of premature birth

May 30, 2012
(Medical Xpress) -- A significant breakthrough on why women go into labour early or develop the disease  pre-eclampsia has been made by scientists. The discovery concerning the conditions which threaten the life of both ...

Escape from the mouse trap? New experimental models developing

January 23, 2012
(Medical Xpress) -- Mark Davis, PhD, director of Stanford’s Institute for Immunity, Transplantation and Infection, has used mice to brilliant effect. They have helped him and a legion of fellow immunologists unravel many ...

Recommended for you

Study highlights the need for research into prevention of inflammatory bowel disease

December 7, 2017
Countries in Africa, Asia, the Middle East and South America have seen a rise in incidence of inflammatory bowel disease as they have become increasingly industrialised and westernised, a new study has found.

Air pollution can increase asthma risk in adults, even at low levels

November 24, 2017
Living close to a busy road can be bad for your respiratory health if you are middle aged, new Australian research has found.

Evidence found of oral bacteria contributing to bowel disorders

October 20, 2017
(Medical Xpress)—An international team of researchers has found evidence that suggests certain types of oral bacteria may cause or exacerbate bowel disorders. In their paper published in the journal Science, the group describes ...

New compound discovered in fight against inflammatory disease

September 22, 2017
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.

Asthma researchers test substance from coralberry leaves

September 14, 2017
The coralberry could offer new hope for asthmatics. Researchers at the University of Bonn have extracted an active pharmaceutical ingredient from its leaves to combat asthma, a widespread respiratory disease. In mice, it ...

Respiratory experts urge rethink of 'outdated' asthma categorisation

September 12, 2017
A group of respiratory medicine experts have called for an overhaul of how asthma and other airways diseases are categorised and treated.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.